Abstract
Background and Aims: Vascular calcification represents a main risk factor of cardiovascular events in patients with chronic kidney disease (CKD). Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) levels correlates with the presence of calcific aortic valve stenosis and carriers of the PCSK9 R46L loss-of-function variant have a low calcific aortic valve stenosis. We investigated a possible role of PCSK9 on aortic calcification.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
